Cargando…
Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study
BACKGROUND: Dual contraceptive method use is defined as the use of any modern contraceptive method with a condom for the reduction of mother-to-child transmission of HIV and sexually transmitted infections between sexual partners. The goal of this study was to assess the proportion and factors assoc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847380/ https://www.ncbi.nlm.nih.gov/pubmed/33531844 http://dx.doi.org/10.2147/HIV.S289045 |
_version_ | 1783644921372082176 |
---|---|
author | Amare, Gashaw Cherie, Niguss Mekonen, Asnakew Molla |
author_facet | Amare, Gashaw Cherie, Niguss Mekonen, Asnakew Molla |
author_sort | Amare, Gashaw |
collection | PubMed |
description | BACKGROUND: Dual contraceptive method use is defined as the use of any modern contraceptive method with a condom for the reduction of mother-to-child transmission of HIV and sexually transmitted infections between sexual partners. The goal of this study was to assess the proportion and factors associated with dual contraceptive use among reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia. OBJECTIVE: To assess the proportion of dual contraceptive use and associated factors among the reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia. METHODS: An institutional-based cross-sectional study was conducted among HIV positive reproductive age group women on antiretroviral therapy in Borena district from February 1 to March 1, 2020. A systematic random sampling technique was used to include 417 study participants. A structured interviewer-administered questionnaire was used to collect the data. A binary logistic regression model was used to identify the factors associated with dual contraceptive use. Odds ratio with 95% confidence interval (CI) and P-value were calculated to assess the strength of association. RESULTS: The results showed that 19.4% of the HIV positive reproductive age group on antiretroviral therapy were using dual contraceptive method. Urban area (AOR=3.66, 95% CI=1.66–8.09), educated to secondary education and above (AOR=3.54, 95% CI=1.29–9.76), those who have no desire to have a child (AOR=4.41, 95% CI=2.66–7.59), those with partners whose HIV status was negative (AOR=4.96, 95% CI=2.66–12.02) and those with partners whose HIV status was positive (AOR=2.45, 95% CI=1.25–4.81) were more likely to use the dual contraception method. CONCLUSION: This study showed that the proportion of dual contraceptive use was found to be low in accordance with the WHO recommendation. Therefore increased awareness on the advantages of dual contraception and knowing partner's HIV status is important. |
format | Online Article Text |
id | pubmed-7847380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78473802021-02-01 Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study Amare, Gashaw Cherie, Niguss Mekonen, Asnakew Molla HIV AIDS (Auckl) Original Research BACKGROUND: Dual contraceptive method use is defined as the use of any modern contraceptive method with a condom for the reduction of mother-to-child transmission of HIV and sexually transmitted infections between sexual partners. The goal of this study was to assess the proportion and factors associated with dual contraceptive use among reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia. OBJECTIVE: To assess the proportion of dual contraceptive use and associated factors among the reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia. METHODS: An institutional-based cross-sectional study was conducted among HIV positive reproductive age group women on antiretroviral therapy in Borena district from February 1 to March 1, 2020. A systematic random sampling technique was used to include 417 study participants. A structured interviewer-administered questionnaire was used to collect the data. A binary logistic regression model was used to identify the factors associated with dual contraceptive use. Odds ratio with 95% confidence interval (CI) and P-value were calculated to assess the strength of association. RESULTS: The results showed that 19.4% of the HIV positive reproductive age group on antiretroviral therapy were using dual contraceptive method. Urban area (AOR=3.66, 95% CI=1.66–8.09), educated to secondary education and above (AOR=3.54, 95% CI=1.29–9.76), those who have no desire to have a child (AOR=4.41, 95% CI=2.66–7.59), those with partners whose HIV status was negative (AOR=4.96, 95% CI=2.66–12.02) and those with partners whose HIV status was positive (AOR=2.45, 95% CI=1.25–4.81) were more likely to use the dual contraception method. CONCLUSION: This study showed that the proportion of dual contraceptive use was found to be low in accordance with the WHO recommendation. Therefore increased awareness on the advantages of dual contraception and knowing partner's HIV status is important. Dove 2021-01-26 /pmc/articles/PMC7847380/ /pubmed/33531844 http://dx.doi.org/10.2147/HIV.S289045 Text en © 2021 Amare et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Amare, Gashaw Cherie, Niguss Mekonen, Asnakew Molla Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study |
title | Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study |
title_full | Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study |
title_fullStr | Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study |
title_full_unstemmed | Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study |
title_short | Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study |
title_sort | dual contraceptive use and associated factors among reproductive age group on antiretroviral therapy in borena district, northeast ethiopia: a cross-sectional study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847380/ https://www.ncbi.nlm.nih.gov/pubmed/33531844 http://dx.doi.org/10.2147/HIV.S289045 |
work_keys_str_mv | AT amaregashaw dualcontraceptiveuseandassociatedfactorsamongreproductiveagegrouponantiretroviraltherapyinborenadistrictnortheastethiopiaacrosssectionalstudy AT cherieniguss dualcontraceptiveuseandassociatedfactorsamongreproductiveagegrouponantiretroviraltherapyinborenadistrictnortheastethiopiaacrosssectionalstudy AT mekonenasnakewmolla dualcontraceptiveuseandassociatedfactorsamongreproductiveagegrouponantiretroviraltherapyinborenadistrictnortheastethiopiaacrosssectionalstudy |